Search Results 111-120 of 25300 for Pulmonary
... pulmonary fibrosis. Questions remain as to the utility of these disease ... pulmonary fibrosis. The exclusion of secondary causes, including ...
Learn the overview, fellowship, accreditation, and history information for the one-year Pulmonary Hypertension Fellowship at Mayo Clinic in Rochester, ...
The purpose of this study is to evaluate the safety and efficacy of AV-101 (dry powder inhaled imatinib) in patients with Pulmonary Arterial Hypertension (PAH).
Mayo Clinic pulmonary function laboratories' updated infection control practices in response to COVID-19 allowed needed testing services to reopen quickly ...
The purpose of this study is to learn more about pulmonary fibrosis and how it develops to determine if the disease can be detected early, before the lung is ...
Treatment for patients with chronic obstructive pulmonary disease (COPD) — including emphysema, chronic bronchitis and COPD exacerbation — can be tailored ...
... pulmonary arterial hypertension (PAH). Pulmonary rehabiltation has been shown to be an effective treatment for patients with chronic obstructive pulmonary ...
Pulmonary rehabiltation has been shown to be an effective treatment for patients with chronic obstructive pulmonary disease, however there is currently a ...
A blood clot blocks and stops blood flow to an artery in the lung. Often the clot starts in a leg and travels to the lung.
Hantavirus pulmonary syndrome is a rare infectious disease that begins with flu-like symptoms and progresses rapidly to more severe disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.